Search Results - "Musaeva, Khedi S."

The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia by Sokolova, Tatiana N., Aleksakhina, Svetlana N., Yanus, Grigoriy A., Sultanbaev, Aleksandr V., Menshikov, Konstantin V., Lysenko, Anna N., Zukov, Ruslan A., Zyuzyukina, Alena V., Murunova, Yulia N., Rossokha, Elena I., Bakharev, Sergey Y., Basova, Elena A., Kasmynina, Tatiana A., Shumskaya, Irina S., Bakshun, Yana I., Musaeva, Khedi S., Khasanova, Alfia I., Dmitriev, Vadim N., Bolieva, Marina B., Gadzaova, Christina H., Petrenko, Oleg L., Maksimov, Dmitriy A., Vladimirov, Vladimir I., Goldberg, Viktor E., Popova, Nataliya O., Kibisheva, Marianna V., Khamgokov, Zaur M., Vasilyev, Alexey E., Iyevleva, Aglaya G., Imyanitov, Evgeny N.

“…Relevance. PIK3CA belongs to the top three most frequently mutated genes in breast cancer (BC), especially in estrogen receptor (ER) positive, HER2 negative BC…”
Get full text

Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia by Orlova, Kristina V., Fedyanin, Mikhail, Simanenkov, Konstantin E., Dergunov, Aleksandr S., Goldshmidt, Petr R., Saydullaeva, Aleksandra F., Bogacheva, Darya V., Yavorskaya, Marina A., Azanov, Artur Z., Fedenko, Alexander A., Bolotina, Larisa V., Deshkina, Tatyana I., Babina, Kseniya G., Kuzevanova, Ekaterina A., Zhukova, Liudmila G., Feoktistova, Polina S., Polshina, Natalya I., Peganova, Ekaterina V., Shikina, Valentina E., Sobolev, Maksim M., Mironov, Oleg V., Vaschenko, Vera A., Ershova, Mariya M., Mezhueva, Agniya O., Orlova, Svetlana A., Tantsyrev, Denis A., Taskina, Darya K., Teterich, Antonina A., Karabina, Elena V., Kostalanova, Yuliya V., Bogacheva, Marina V., Zhukova, Natalia V., Orlova, Rashida V., Zinkevich, Maksim V., Kazmin, Aleksandr I., Volkonskiy, Mikhail V., Voronkova, Liya M., Karpova, Anastasiya S., Maleyko, Mikhail L., Gorshenina, Mariya N., Kryuchkova, Elena I., Moiseenko, Fedor V., Murzina, Yuliya I., Musin, Shamil I., Ogloblin, Andrey N., Perminova, Mariya S., Dumbrava, Regina A., Emelyanov, Sergey A., Protsenko, Svetlana A., Sultanbaev, Alexander V., Tarasova, Anna V., Shakhnovich, Elena B., Demchenkova, Marina V., Lozovskaya, Yuliya A., Musaeva, Khedi S., Pavlova, Elena M., Skotnikov, Roman A., Chernova, Vera V., Chichkanova, Angelina S., Akhmatova, Adina M., Zafirova, Marina A., Mischenko, Andrey A., Ovsienko, Elena N., Petrukhnenko, Viktoriya A., Syusyukaylova, Oksana A., Tyugina, Yana A., Shumilkina, Elena A., Stroyakovskiy, Daniil L., Yurchenkov, Aleksandr N., Baldin, Pavel L., Belova, Anastasiya S., Diduk, Olga V., Konovalova, Elena A., Lebedeva, Lyudmila N., Li, Yaroslav A., Mashtapa, Viktoriya V., Mironenkova, Yana A., Narovenkova, Kristina V., Pavlikova, Olga A., Parsadanova, Elvira L., Pimonova, Irina S., Ruzhnikova, Anna A., Sivunova, Irina D., Soloveva, Ekaterina P., Sosnin, Maksim I., Temirsultanova, Kh. Toita, Tyulegenova, Makhabbat Zh, Khodkevich, Aleksandra V., Shakurova, Nadezhda R., Efendieva, Sureya N., Avagimyan, Karine L., Anokhina, Ekaterina Р., Antoshkina, Mariya I., Borzyanitsa, Stanislav M., Dzhentemirov, Samir K., Dmitrochenko, Marina V., Zheleznyak, Alla V., Komoza, Yuliya V., Kopanev, Aleksandr S., Kornienko, Tatyana I.

“…Background. Prior to the introduction of new agents — immune checkpoint inhibitors — for inoperable and/or metastatic melanoma (IMM), chemotherapy outcomes…”
Get full text